首页> 外文OA文献 >Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium

【2h】

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium

机译：探讨CD133 /醛 - 脱氢酶-1（aLDH1）阳性癌干细胞样细胞从原发性高级浆液性卵巢癌（HGsOC）的克隆演变。一项关于卵巢癌治疗 - 创新模式延长生存（OCTIps）联盟的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ruscito, I; Castillo-Tong, DC; Vergote, I; Ignat, I; Stanske, M; Vanderstichele, A; Ganapathi, RN; Glajzer, J; Kulbe, H; Trillsch, F; Mustea, A; Kreuzinger, C; Panici, PB; Gourley, C; Gabra, H; Kessler, M; Sehouli, J; Darb-Esfahani, S; Braicu, EI;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium [J] . Ruscito Ilary, Castillo-Tong Dan Cacsire, Vergote Ignace, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：探索CD133 /醛 - 脱氢酶-1（ALDH1） - 阳性癌症状细胞的克隆演化从初发于经常性高级浆液癌（HGSOC）。卵巢癌治疗 - 创新模型的研究延长生存（八层）财团
2. Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium [J] . Guan Jun, Darb-Esfahani Silvia, Richter Rolf, Journal of Cancer Research and Clinical Oncology . 2019,第4期

机译：血管内皮生长因子受体2（VEGFR2）与晚期高级浆液癌患者（HGSOC）的长期存活相关：肿瘤库卵巢癌（TOC）联盟的研究
3. Clonal Evolution of TP53 c.375+1GA Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) [J] . Marica Garziera, Erika Cecchin, Giorgio Giorda, Cells . 2019,第10期

机译：TP53 C.375 + 1G的克隆演化>新辅助化疗（NACT）肿瘤样品中的突变（NACT）肿瘤癌（HGSOC）
4. CD133-positive cancer stem-like cells ablated by gold nanorod-mediated near-infrared laser treatment [C] . Peng Ching-An, Wang Chung-Hao 2011 IEEE 4th International Nanoelectronics Conference . 2011

机译：金纳米棒介导的近红外激光治疗消融CD133阳性癌症干细胞
5. Characterization of Precancerous Mutations in Ulcerative Colitis-Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing [D] . Baker, Kathryn Terese 2018

机译：溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
6. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study). [O] . Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, 2018

机译：高级别浆液性卵巢癌进展过程中肿瘤微血管密度的特征：临床病理影响（OCTIPS联盟研究）。
7. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium. [O] . Ruscito, I, Cacsire Castillo-Tong, D, Vergote, I, 2017

机译：探索CD133 /醛脱氢酶-1（ALDH1）阳性癌症干样细胞从原发性到复发性高级别浆液性卵巢癌（HGSOC）的克隆进化。卵巢癌治疗创新模型延长生存期（OCTIPS）联盟的研究。

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium

著录项

相似文献

相关主题

期刊订阅